Efficacy and Safety of Denosumab Compared With Risedronate in Individuals Taking Glucocorticoids

Completed · Phase 3 · Has a placebo group

Conditions studied: Steroid-induced Osteopor, Glucocorticoid-induced Ostepor

In brief

This is a 2-year study to evaluate the effect of denosumab versus risedronate in adults with glucocorticoid-induced osteoporosis.

Key facts

Study ID
NCT01575873
Run by
Amgen
People needed
795
Starts
2012-03-28
Expected to finish
2017-06-29
Last updated by the study team
2018-07-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.